Malvern Experts Bring Advanced Near Infrared Chemical Imaging to FACSS 2008
News Jul 28, 2008
Experts from Malvern Instruments’ analytical imaging team will present advanced methods and new techniques using near infrared chemical imaging (NIR-CI) at this year’s Federation of Chemical and Spectroscopy Societies annual meeting.
FACSS 2008 (Sept. 28 - Oct. 2, 2008, Reno NV, USA www.facss.org) aims to bring ‘tomorrow’s analytical sciences today’, to analytical chemists and spectroscopists, and all three presentations from Malvern will certainly meet that goal.
Malvern’s Technical Director Dr E. Neil Lewis, and colleagues will present: Hybrid Analytical Approaches: Simultaneous Physical and Chemical Characterization as a Tool for Pharmaceutical Quality by Design at the Charles Mann Award Session. This paper describes a new technique for combining morphological and chemical information in a single measurement.
Other Malvern specialists will give papers on; Chemical and Morphological Imaging of Pharmaceutical Products: Measuring the Impact of Process Conditions on Finished Tablets at the Vibrational Spectroscopy, Chemical Imaging and QbD session, and Advanced Methods Characterizing Spatial Heterogeneity in Chemical Imaging Data Analysis as part of the session covering Chemometrics Along Spatial and Chemical Dimensions.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018